RS
Reena Sajesh
About Reena Sajesh
Data last updated:
Reena Sajesh is a Director at Swapriya Estates And Investments Private Limited (since 2018) and Managing Director at Asepsis Pharmaceuticals Private Limited (since 2017). The companies operate in Real Estate and Chemicals. The largest current company by reported revenue is Swapriya Estates And Investments Private Limited at ₹7.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2018 | 1997 | ₹7.5 Lakh (FY 2025) | Active | |
| Managing Director | 02 Jan 2017 | 2017 | Active |
Board colleagues of Reena Sajesh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sajesh Sidharthan Thottupura | 07531844 | Swapriya Estates And Investments Private Limited , Asepsis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Reena Sajesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reena Sajesh
Reena Sajesh currently holds 2 directorships: Swapriya Estates And Investments Private Limited (Director, since 01 Apr 2018, revenue ₹7.5 Lakh (FY 2025)); Asepsis Pharmaceuticals Private Limited (Managing Director, since 02 Jan 2017).
Reena Sajesh was first appointed on 02 Jan 2017 as Managing Director at Asepsis Pharmaceuticals Private Limited. The most recent appointment on record is 01 Apr 2018 at Swapriya Estates And Investments Private Limited.
The current boards of Reena Sajesh's companies include Sajesh Sidharthan Thottupura (Swapriya Estates And Investments Private Limited).